| Company Name: |
Quality Control Solutions Ltd.
|
| Tel: |
0755-66853366 13670046396 |
| Email: |
orders@qcsrm.com |
| Products Intro: |
Product Name:Nalfurafine Impurity 4
CAS:163712-68-3
Purity:95% HPLC Package:10mg;25mg;50mg
|
| Company Name: |
TOSUN PHARM
|
| Tel: |
020-66392521-118 18922260391 |
| Email: |
3004261881@qq.com |
| Products Intro: |
Product Name:Nalfuranfine Impurity 7
CAS:163712-68-3
Purity:98%以上 Package:10mg;50mg;100mg等多种规格 Remarks:REF-N06008
|
| Company Name: |
Hubei Xinyang Medical Technology Co., Ltd
|
| Tel: |
15347293736 |
| Email: |
2853117764@yongstandards.com |
| Products Intro: |
Product Name:Nalfurafine Impurity 6
CAS:163712-68-3
Purity:99% Package:10mg;50mg;100mg
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:2Z-Nalfurafine
CAS:163712-68-3
Purity:NULL Package:50mg;5mg Remarks:NULL
|
|
| | XGZZHZMWIXFATA-VQNNHZPYSA-N Basic information |
| Product Name: | XGZZHZMWIXFATA-VQNNHZPYSA-N | | Synonyms: | XGZZHZMWIXFATA-VQNNHZPYSA-N;2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (Z)- (9CI);(Z)-N-((4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)-3-(furan-3-yl)-N-methylacrylamide;Controlled Substance(Nalfurafine Impurity 4) | | CAS: | 163712-68-3 | | MF: | C28H32N2O5 | | MW: | 476.57 | | EINECS: | | | Product Categories: | | | Mol File: | 163712-68-3.mol |  |
| | XGZZHZMWIXFATA-VQNNHZPYSA-N Chemical Properties |
| Boiling point | 700.7±60.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | 9.37±0.60(Predicted) |
| | XGZZHZMWIXFATA-VQNNHZPYSA-N Usage And Synthesis |
| Uses | 2Z-Nalfurafine-d3 is the labeled analogue of 2Z-Nalfurafine (N255610), a geometric isomer of Nalfurafine (N255600), a on-narcotic opioid drug for intractable itch caused by hemodialysis. It showed significant opioid κ-agonist activity and induced neither aversion nor preference in rats on the CPP (Conditioned Place Preference) test. Nalfurafine is a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients. |
| | XGZZHZMWIXFATA-VQNNHZPYSA-N Preparation Products And Raw materials |
|